Show simple item record

dc.contributor.authorDobson, M
dc.contributor.authorCarrington, Bernadette M
dc.contributor.authorRadford, John A
dc.contributor.authorBuckley, C H
dc.contributor.authorCrowther, Derek
dc.date.accessioned2010-03-24T14:12:32Z
dc.date.available2010-03-24T14:12:32Z
dc.date.issued1997-04
dc.identifier.citationThe role of computed tomography in the management of ovarian tumours of borderline malignancy. 1997, 52 (4):280-3 Clin Radiolen
dc.identifier.issn0009-9260
dc.identifier.pmid9112945
dc.identifier.urihttp://hdl.handle.net/10541/94865
dc.description.abstractOvarian tumours of borderline malignancy are a distinct histological and clinical entity diagnosed in up to 15% of patients presenting with an ovarian neoplasm. Compared with frankly malignant tumours, they have a much better prognosis, present at an earlier age, and the majority are stage 1 at diagnosis. This study reviewed 35 patients with ovarian tumours of borderline malignancy referred to the CRC Medical Oncology Unit at The Christie Hospital over a 9-year period and evaluated the role of diagnostic imaging, in particular, the value of postoperative computed tomography (CT). We conclude that in cases of FIGO stage 1 disease where there is complete macroscopic removal of tumour, there is no need for further routine imaging. If chemotherapy is to be given for patients with more advanced disease, a baseline postoperative abdomino-pelvic CT scan and a post-treatment scan are appropriate investigations.
dc.language.isoenen
dc.subjectCancer Stagingen
dc.subjectResidual Canceren
dc.subjectOvarian Canceren
dc.subject.meshAdult
dc.subject.meshAged
dc.subject.meshFemale
dc.subject.meshFollow-Up Studies
dc.subject.meshHumans
dc.subject.meshMiddle Aged
dc.subject.meshNeoplasm Staging
dc.subject.meshNeoplasm, Residual
dc.subject.meshOvarian Neoplasms
dc.subject.meshPostoperative Care
dc.subject.meshPrognosis
dc.subject.meshTomography, X-Ray Computed
dc.titleThe role of computed tomography in the management of ovarian tumours of borderline malignancy.en
dc.typeArticleen
dc.contributor.departmentDepartment of Diagnostic Radiology, Christie Hospital, Manchester, UK.en
dc.identifier.journalClinical Radiologyen
html.description.abstractOvarian tumours of borderline malignancy are a distinct histological and clinical entity diagnosed in up to 15% of patients presenting with an ovarian neoplasm. Compared with frankly malignant tumours, they have a much better prognosis, present at an earlier age, and the majority are stage 1 at diagnosis. This study reviewed 35 patients with ovarian tumours of borderline malignancy referred to the CRC Medical Oncology Unit at The Christie Hospital over a 9-year period and evaluated the role of diagnostic imaging, in particular, the value of postoperative computed tomography (CT). We conclude that in cases of FIGO stage 1 disease where there is complete macroscopic removal of tumour, there is no need for further routine imaging. If chemotherapy is to be given for patients with more advanced disease, a baseline postoperative abdomino-pelvic CT scan and a post-treatment scan are appropriate investigations.


This item appears in the following Collection(s)

Show simple item record